Table 1. Summary of previous reports and present case.
| Author and year | Lee 2008 | Lee 2008 | Ichikawa 2002 | Ueno 2017 | Present case |
| Age (year) | 27 | 30 | 47 | 68 | 65 |
| Sex | Female | Male | Male | Male | Male |
| Preceding vaccination | (-) | (-) | (-) | (-) | COVID-19 (Pfizer) |
| Preceding infection | Gastroenteritis | URI | URI | Gastroenteritis | (-) |
| Time between preceding event and onset | NA | NA | 14 days | 8 days | 17 days |
| Affected eye side | Right | Right | Left | Right | Right |
| Ptosis | (-) | (+) | (+) | (+) | (+) |
| Gage limitation | Vertical | Adduction and vertical | Adduction and vertical | Adduction and vertical | Adduction and vertical |
| Ataxia | (-) | (-) | (-) | (-) | (-) |
| Deep tendon reflex | Normal | Decreased | Normal | Decreased | Normal |
| CSF | Normal | Albuminocytologic dissociation | Albuminocytologic dissociation | Normal | Albuminocytologic dissociation |
| NCS | Normal | Normal | Normal | Normal | Normal |
| Contrast-enhanced MRI | NA | NA | NA | NA | Enhancement in
oculomotor nerve |
| Treatment | IVIG or Steroid | IVIG or Steroid | IVIG and Steroid | No | IVIG |
| Recovery period | Follow up loss | 6 months | 28 days | 44 days | 36 days (mild improvement) |
URI, upper respiratory infection; CSF, cerebrospinal fluid; NCS, Nerve conduction study; MRI, magnetic resonance imaging; NA, Not available; IVIG, intravenous immunoglobulin.